Viewing Study NCT03965858


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-03-11 @ 6:06 PM
Study NCT ID: NCT03965858
Status: COMPLETED
Last Update Posted: 2020-04-28
First Post: 2019-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression
Sponsor: Celon Pharma SA
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 02KET2018
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View